Editorial board disclosure policy
Journal of Endocrinology and Journal of Molecular Endocrinology Disclosure Policy
(Last updated January 2024)
All editors responsible for recommending or making publication decisions are requested to disclose on an annual basis any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content.
The following competing interests were disclosed:
Professor Simak Ali
Professor Ali owns shares in Carrick Therapeutics Ltd and has received royalties for a patent that has been licensed to Carrick Therapeutics Ltd. He has also received consultancy money from Carrick Therapeutics Ltd in 2017 and received a MRC PhD studentship jointly with Astra Zeneca (2018–2020).
Professor Ali owns shares in Carrick Therapeutics Ltd and has received royalties for a patent that has been licensed to Carrick Therapeutics Ltd. He has also received consultancy money from Carrick Therapeutics Ltd in 2017 and received a MRC PhD studentship jointly with Astra Zeneca (2018–2020).
Professor Ian Bird
Professor Bird has funding from NIH, mostly T32 training grants, CoI as a sample collection core PI on a Pediatric network study (ECHO Coordination study). He is currently leading a P01 application to NHLBI on preeclamptic pregnancy. He reviews for NIH, principally at NICHD but sometimes NHLBI and NIGMS. Professor Bird is active in Society Reproductive Investigation and Perinatal Research Society, and has held past leadership offices in both. He has a patent in consideration for the use of Conjugated Linoleic Acid to treat preeclampsia.
Professor Bird has funding from NIH, mostly T32 training grants, CoI as a sample collection core PI on a Pediatric network study (ECHO Coordination study). He is currently leading a P01 application to NHLBI on preeclamptic pregnancy. He reviews for NIH, principally at NICHD but sometimes NHLBI and NIGMS. Professor Bird is active in Society Reproductive Investigation and Perinatal Research Society, and has held past leadership offices in both. He has a patent in consideration for the use of Conjugated Linoleic Acid to treat preeclampsia.
Professor Wendy Bollag
Professor Bollag is listed as an inventor of the following patents: US Patent No 8,808,715 and US Patent No 8,524,692.
Professor Bollag is listed as an inventor of the following patents: US Patent No 8,808,715 and US Patent No 8,524,692.
Dr Georgios K Dimitriadis
Dr Dimitriadis has received adhoc honoraria for advisory board fees from Novo Nordisk and research grants from Novo Nordisk UK Research Foundation. He has received honoraria for talks given during educational events for Novo Nordisk, Medtronic, Napp, Pharmasure and Ethicon/J&J. He is also a senior editor on Endocrinology, Diabetes and Metabolism Case Reports.
Dr Dimitriadis has received adhoc honoraria for advisory board fees from Novo Nordisk and research grants from Novo Nordisk UK Research Foundation. He has received honoraria for talks given during educational events for Novo Nordisk, Medtronic, Napp, Pharmasure and Ethicon/J&J. He is also a senior editor on Endocrinology, Diabetes and Metabolism Case Reports.
Professor Colin Farquharson
Professor Farquharson has received personal fees for his work on the HBLB VAC committee.
Professor Farquharson has received personal fees for his work on the HBLB VAC committee.
Professor Martin Haluzik
Professor Haluzik is on the advisory panel and has received lecture fees for: Novo Nordisk, Sanofi, Eli Lilly, Novartis, Johnson Johnson, Astra Zeneca and Mundipharma. He is also on the advisory panel for Medtronic and has received lecture fees from Merck.
Professor Haluzik is on the advisory panel and has received lecture fees for: Novo Nordisk, Sanofi, Eli Lilly, Novartis, Johnson Johnson, Astra Zeneca and Mundipharma. He is also on the advisory panel for Medtronic and has received lecture fees from Merck.
Dr Rebecca Hull
Dr Hull has received research funding from Boehringer Ingelheim.
Dr Hull has received research funding from Boehringer Ingelheim.
Dr Lenka Maletínská
Dr Maletínská has a license agreement and research grant with Novo Nordisk (2017-2022). She has also been granted the following patents, 2019-2021: Lipidated peptides for lowering blood glucose, US2015/0196651 (granted 15.5.20190), IL 246618 (granted 1.5.2021); Lipidized peptides as neuroprotective agents, US10,751,390 (granted 25.8.2020), IL 248370 (granted 29.2.2020), EP 3149029 (granted 19.6.2019) and CA2.950.416 (granted 2.3.2021).
Dr Maletínská has a license agreement and research grant with Novo Nordisk (2017-2022). She has also been granted the following patents, 2019-2021: Lipidated peptides for lowering blood glucose, US2015/0196651 (granted 15.5.20190), IL 246618 (granted 1.5.2021); Lipidized peptides as neuroprotective agents, US10,751,390 (granted 25.8.2020), IL 248370 (granted 29.2.2020), EP 3149029 (granted 19.6.2019) and CA2.950.416 (granted 2.3.2021).
Dr Steve Millership
Dr Millership received a Speaker honorarium of £750 for SfE non-clinical early career prize lecture, BES, November 2020, and received travel expenses to SfE BES 2022 and 2023. He is a Frontiers review editor and a member of the SfE Science Committee.
Dr Millership received a Speaker honorarium of £750 for SfE non-clinical early career prize lecture, BES, November 2020, and received travel expenses to SfE BES 2022 and 2023. He is a Frontiers review editor and a member of the SfE Science Committee.
Dr Mark Turner
Dr Turner has received funding from BBSRC/MRC MyAge Network, the Society for Endocrinology Early Career Grants and Animal Free Research UK in collaboration with Kirkstall. He is receiving financial support to conduct contractual research with the nutrition company, Snowdonia. Dr Turner is an External Examiner & Visiting Lecturer, Division of Medicine at University College London. As a result of his roles in the commitees for the Society for Endocrinology, he has recived travel expenses to attend meetings and other related events. Dr Turner is the Chair of the Early Career Committee and an Ex officio member of Council for the Society for Endocrinology. He was recently a guest editor for the MDPI journal Nutrients, for the special issue on Diet, Adipose Tissue Dysfunction and Metabolic Disorders.
Dr Turner has received funding from BBSRC/MRC MyAge Network, the Society for Endocrinology Early Career Grants and Animal Free Research UK in collaboration with Kirkstall. He is receiving financial support to conduct contractual research with the nutrition company, Snowdonia. Dr Turner is an External Examiner & Visiting Lecturer, Division of Medicine at University College London. As a result of his roles in the commitees for the Society for Endocrinology, he has recived travel expenses to attend meetings and other related events. Dr Turner is the Chair of the Early Career Committee and an Ex officio member of Council for the Society for Endocrinology. He was recently a guest editor for the MDPI journal Nutrients, for the special issue on Diet, Adipose Tissue Dysfunction and Metabolic Disorders.
Dr Jennifer Wood
Dr Wood serves as an associate editor of Frontiers in Molecular and Cellular Reproduction, and is Vice President of the Society for the Study of Reproduction.
Dr Wood serves as an associate editor of Frontiers in Molecular and Cellular Reproduction, and is Vice President of the Society for the Study of Reproduction.
Dr Xiaoyong Yang
Dr Yang has received research grants from The National Insititutes of Health, American Diabetes Association and American Cancer Society. He received or will receive the speaker’s honoraria from the following insitutions: University of Pennsylvania, University of Alabama at Birmingham, The George Washington University, University of Nebraska-Lincoln, Wayne State University, University of New Mexico, UT Health San Antonio, Chinese Diabetes Society, Singapore Agency for Science, Technology and Research. Dr Yang serves as an associate editor of Frontiers in Endocrinology, founding associate editor of Frontiers in Aging, and an editorial board member of Journal of Biological Chemistry and Life Metabolism.
Dr Yang has received research grants from The National Insititutes of Health, American Diabetes Association and American Cancer Society. He received or will receive the speaker’s honoraria from the following insitutions: University of Pennsylvania, University of Alabama at Birmingham, The George Washington University, University of Nebraska-Lincoln, Wayne State University, University of New Mexico, UT Health San Antonio, Chinese Diabetes Society, Singapore Agency for Science, Technology and Research. Dr Yang serves as an associate editor of Frontiers in Endocrinology, founding associate editor of Frontiers in Aging, and an editorial board member of Journal of Biological Chemistry and Life Metabolism.
Dr Morag Young
Dr Young has received a research grant from AstraZeneca and NHMRC of Australia, research grants ending Dec 2019. She is also involved with new AstraZeneca MR antagonist for in vitro experimental studies and new Bayer MR antagonist for in vitro experimental studies.
Dr Young has received a research grant from AstraZeneca and NHMRC of Australia, research grants ending Dec 2019. She is also involved with new AstraZeneca MR antagonist for in vitro experimental studies and new Bayer MR antagonist for in vitro experimental studies.
The following editors reported no competing interests:
- Dr Anita Boelen
- Dr Eugenia Carvalho
- Professor Barbara Clark
- Professor Alan J Conley
- Professor Sean Limesand
- Dr Raul M Luque
- Dr Ernesto Podesta
- Professor Weiping Zhang
Bioscientifica staff and freelancers working on the journal reported no conflicts of interest. Article authors' declarations are stated in each journal article. Referees must disclose any competing interests before agreeing to review any submission. For more information on the journal’s ethical policy, please read the ethical guidelines.
This policy follows the recommendations of the International Committee of Medical Journals Editors (ICMJE) and the Committee on Publication Ethics (COPE).
